Pure Global

BALVERSA 3 MG FILM COATED TABLET, 84 PCS - Turkey License 8267b11a7d39b8db8a443abf03b6b71f

Access comprehensive regulatory information for BALVERSA 3 MG FILM COATED TABLET, 84 PCS in Turkey's pharmaceutical market through Pure Global AI's free database. This pharmaceutical product is licensed under Turkey number 8267b11a7d39b8db8a443abf03b6b71f with license number 2022/596and contains active ingredient Erdafitinib . The license is held by JOHNSON AND JOHNSON SIHHİ MAL. SAN. VE TİC. LTD. ŞTİ..

This page provides complete pharmaceutical specifications, regulatory compliance details. Pure Global AI offers free access to 21,000+ Turkish pharmaceutical product licenses, helping global pharma companies navigate Turkey SFDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
21,000+ Products
8267b11a7d39b8db8a443abf03b6b71f
License Details
Turkey SFDA License: 8267b11a7d39b8db8a443abf03b6b71f
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Product Details

BALVERSA 3 MG FILM COATED TABLET, 84 PCS
TR: BALVERSA 3 MG FİLM KAPLI TABLET, 84 ADET
Pharmaceutical Product

License Details

8267b11a7d39b8db8a443abf03b6b71f

2022/596

8699593095634

L01EN01

License Holder Information

Active Ingredient

Erdafitinib

License Information

Oct 18, 2022